P. Wood

Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials.

J. Kurhanewicz, M. Swanson, D. Vigneron, 2001, Urology.

Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging

J Kurhanewicz, S J Nelson, D B Vigneron, 2001, Magnetic resonance in medicine.

The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer

K. Yousefi, E. Davicioni, N. Erho, 2016 .